Literature DB >> 17825579

Soluble HLA-G: Are they clinically relevant?

Vito Pistoia1, Fabio Morandi, Xinhui Wang, Soldano Ferrone.   

Abstract

HLA-G is a non-classical HLA-class Ib molecule with multiple immunoregulatory properties. Its main function in physiological conditions is to abrogate maternal NK cell activity against foetal tissue and to establish immune tolerance at maternal-foetal interface. HLA-G is expressed not only as a membrane bound molecule on the surface of cells, but also as a soluble moiety in body fluids. The major isoforms of HLA-G present in serum are soluble HLA-G1 and HLA-G5 which are generated by shedding or proteolytic cleavage of the membrane bound isoform and by secretion of a soluble isoform, respectively. Here we review the data about soluble HLA-G (sHLA-G) serum levels in different pathological conditions, including immune-mediated disorders, transplantation and malignancies. In particular, we focus on sHLA-G expression and function in human neuroblastoma, a pediatric tumor, with special emphasis on a novel potential immuno escape mechanism utilized by NB to instruct monocytes to produce and release sHLA-G. Finally, the potential clinical relevance of sHLA-G serum levels is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825579      PMCID: PMC2200630          DOI: 10.1016/j.semcancer.2007.07.004

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  71 in total

Review 1.  Stranger in a strange land.

Authors:  Joan S Hunt
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

2.  Soluble HLA-G expression and renal graft acceptance.

Authors:  J Qiu; P I Terasaki; J Miller; K Mizutani; J Cai; E D Carosella
Journal:  Am J Transplant       Date:  2006-06-19       Impact factor: 8.086

3.  Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos.

Authors:  Vera Rebmann; Magdalena Switala; Ines Eue; Eva Schwahn; Markus Merzenich; Hans Grosse-Wilde
Journal:  Hum Immunol       Date:  2006-12-22       Impact factor: 2.850

4.  Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells.

Authors:  Pierre Fons; Sophie Chabot; Judith E Cartwright; Francoise Lenfant; Fatima L'Faqihi; Jerome Giustiniani; Jean-Pascal Herault; Genevieve Gueguen; Françoise Bono; Pierre Savi; Maryse Aguerre-Girr; Sylvie Fournel; François Malecaze; Armand Bensussan; Jean Plouët; Philippe Le Bouteiller
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

5.  Soluble HLA-G in rheumatoid arthritis.

Authors:  Leon A Verbruggen; Vera Rebmann; Christian Demanet; Seija De Cock; Hans Grosse-Wilde
Journal:  Hum Immunol       Date:  2006-05-05       Impact factor: 2.850

6.  HLA-G expression in gastric cancer.

Authors:  Sumiya Ishigami; Shoji Natsugoe; Futoshi Miyazono; Aikihiro Nakajo; Koki Tokuda; Masataka Matsumoto; Hiroshi Okumura; Tsutomu Douchi; Shuichi Hokita; Takashi Aikou
Journal:  Anticancer Res       Date:  2006 May-Jun       Impact factor: 2.480

7.  Plasma soluble human leukocyte antigen G levels in asthmatic children.

Authors:  Fulya Tahan; Turkan Patiroglu
Journal:  Int Arch Allergy Immunol       Date:  2006-08-22       Impact factor: 2.749

8.  Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells.

Authors:  A van der Meer; H G M Lukassen; B van Cranenbroek; E H Weiss; D D M Braat; M J van Lierop; I Joosten
Journal:  Mol Hum Reprod       Date:  2006-11-22       Impact factor: 4.025

9.  Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells.

Authors:  Joel LeMaoult; Julien Caumartin; Marina Daouya; Benoit Favier; Solene Le Rond; Alvaro Gonzalez; Edgardo D Carosella
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

10.  Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma.

Authors:  Breton F Barrier; Brian S Kendall; Kathy L Sharpe-Timms; Edward R Kost
Journal:  Gynecol Oncol       Date:  2006-03-10       Impact factor: 5.482

View more
  51 in total

Review 1.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

2.  Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.

Authors:  Giuseppe Murdaca; Paola Contini; Paola Cagnati; Simona Marenco; Giulia Pieri; Francesca Lantieri; Antonino Picciotto; Francesco Puppo
Journal:  Clin Exp Med       Date:  2015-11-14       Impact factor: 3.984

Review 3.  Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions.

Authors:  Julia Kravchenko; Emanuela Corsini; Marc A Williams; William Decker; Masoud H Manjili; Takemi Otsuki; Neetu Singh; Faha Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson; Leroy Lowe; H Kim Lyerly
Journal:  Carcinogenesis       Date:  2015-05-22       Impact factor: 4.944

4.  HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact.

Authors:  Giuseppe Murdaca; Paola Calamaro; Francesca Lantieri; Simona Pigozzi; Luca Mastracci; Federica Grillo; Ottavia Magnani; Paola Ceppa; Francesco Puppo; Roberto Fiocca
Journal:  Virchows Arch       Date:  2018-05-29       Impact factor: 4.064

5.  Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.

Authors:  Inès Zidi; Olfa Dziri; Nour Zidi; Refaat Sebai; Nadia Boujelebene; Amna Ben Hassine; Hamza Ben Yahia; Ahmed Baligh Laaribi; Wafa Babay; Hela Rifi; Amel Mezlini; Hanene Chelbi
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

6.  Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.

Authors:  Fabio Morandi; Vito Pistoia
Journal:  Int Immunol       Date:  2012-12-05       Impact factor: 4.823

Review 7.  Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.

Authors:  M Campoli; S Ferrone
Journal:  Tissue Antigens       Date:  2008-08-12

Review 8.  HLA-G: a human pregnancy-related immunomodulator.

Authors:  Joan S Hunt; Daudi L Langat
Journal:  Curr Opin Pharmacol       Date:  2009-06-29       Impact factor: 5.547

Review 9.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

10.  Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords.

Authors:  R H McIntire; T Sifers; J S Platt; K G Ganacias; D K Langat; J S Hunt
Journal:  Placenta       Date:  2008-06-05       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.